1. 52-Week clinical efficacy with adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressants. (13th March 2011) Authors: Reinisch, W; Sandborn, W J; Kumar, A; Pollack, P F; Lazar, A; Thakkar, R B Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Achievement of early deep remission is associated with lower rates of weekly dosing for adalimumab-treated patients with crohn's disease: data from extend. (13th March 2011) Authors: Sandborn, W J; Colombel, J F; Lomax, K G; Pollack, P F; Thakkar, R; Camez, A; Chen, N; Yang, M; Chao, J; Mulani, P M Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Issue 9 (13th February 2007) Authors: Sandborn, W J; Hanauer, S B; Rutgeerts, P; Fedorak, R N; Lukas, M; MacIntosh, D G; Panaccione, R; Wolf, D; Kent, J D; Bittle, B; Li, J; Pollack, P F Journal: Gut Issue: Volume 56:Issue 9(2007) Page Start: 1232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Issue 7 (6th February 2009) Authors: Colombel, J-F; Schwartz, D A; Sandborn, W J; Kamm, M A; D'Haens, G; Rutgeerts, P; Enns, R; Panaccione, R; Schreiber, S; Li, J; Kent, J D; Lomax, K G; Pollack, P F Journal: Gut Issue: Volume 58:Issue 7(2009) Page Start: 940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Markov model projection of remission status for early versus delayed step-up adalimumab use in moderate to severe crohn's disease. (13th March 2011) Authors: Loftus, E V; Chao, J; Yang, M; Pollack, P F; Li, Z; Thakkar, R B; Mulani, P M Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PWE-254 Impact of induction dosing on maintenance outcome with adalimumab in Crohn's disease. (28th May 2012) Authors: Colombel, J-F; Rutgeerts, P J; Sandborn, W J; Reinisch, W; Loftus, E V; Tang, J; Pollack, P F; Yang, M; Patel, S P; Huang, B; Chao, J; Mulani, P M Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗